| Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide R Azriel, E Gazit Journal of Biological Chemistry 276 (36), 34156-34161, 2001 | 475 | 2001 |
| A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes T Noy-Porat, E Makdasi, R Alcalay, A Mechaly, Y Levy, A Bercovich-Kinori, ... Nature communications 11 (1), 4303, 2020 | 135 | 2020 |
| Highly efficient selection of phage antibodies mediated by display of antigen as Lpp-OmpA′ fusions on live bacteria I Benhar, R Azriel, L Nahary, S Shaky, Y Berdichevsky, A Tamarkin, ... Journal of molecular biology 301 (4), 893-904, 2000 | 93 | 2000 |
| Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles U Elia, S Ramishetti, R Rosenfeld, N Dammes, E Bar-Haim, GS Naidu, ... ACS nano 15 (6), 9627-9637, 2021 | 73 | 2021 |
| A human synthetic combinatorial library of arrayable single-chain antibodies based on shuffling in vivo formed CDRs into general framework regions R Azriel-Rosenfeld, M Valensi, I Benhar Journal of molecular biology 335 (1), 177-192, 2004 | 73 | 2004 |
| Versatile protein microarray based on carbohydrate‐binding modules K Ofir, Y Berdichevsky, I Benhar, R Azriel‐Rosenfeld, R Lamed, Y Barak, ... Proteomics 5 (7), 1806-1814, 2005 | 69 | 2005 |
| Antibody molecules discriminate between crystalline facets of a gallium arsenide semiconductor A Artzy Schnirman, E Zahavi, H Yeger, R Rosenfeld, I Benhar, Y Reiter, ... Nano letters 6 (9), 1870-1874, 2006 | 54 | 2006 |
| Spike vs nucleocapsid SARS-CoV-2 antigen detection: application in nasopharyngeal swab specimens M Barlev-Gross, S Weiss, A Ben-Shmuel, A Sittner, K Eden, N Mazuz, ... Analytical and Bioanalytical Chemistry 413, 3501-3510, 2021 | 52 | 2021 |
| Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody R Rosenfeld, T Noy-Porat, A Mechaly, E Makdasi, Y Levy, R Alcalay, ... Nature communications 12 (1), 944, 2021 | 51 | 2021 |
| Isolation of anti-ricin protective antibodies exhibiting high affinity from immunized non-human primates T Noy-Porat, R Rosenfeld, N Ariel, E Epstein, R Alcalay, A Zvi, C Kronman, ... Toxins 8 (3), 64, 2016 | 47 | 2016 |
| A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion A Mechaly, H Levy, E Epstein, R Rosenfeld, H Marcus, E Ben-Arie, ... Journal of Biological Chemistry 287 (39), 32665-32673, 2012 | 36 | 2012 |
| Isolation and chimerization of a highly neutralizing antibody conferring passive protection against lethal Bacillus anthracis infection R Rosenfeld, H Marcus, E Ben-Arie, BE Lachmi, A Mechaly, S Reuveny, ... PLoS One 4 (7), e6351, 2009 | 35 | 2009 |
| Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice T Noy-Porat, A Mechaly, Y Levy, E Makdasi, R Alcalay, D Gur, M Aftalion, ... Iscience 24 (5), 2021 | 31 | 2021 |
| Neutralizing monoclonal anti-SARS-CoV-2 antibodies isolated from immunized rabbits define novel vulnerable spike-protein epitope E Makdasi, Y Levy, R Alcalay, T Noy-Porat, E Zahavy, A Mechaly, ... Viruses 13 (4), 566, 2021 | 25 | 2021 |
| Lipid nanoparticle RBD-hFc mRNA vaccine protects hACE2 transgenic mice against a lethal SARS-CoV-2 infection U Elia, S Rotem, E Bar-Haim, S Ramishetti, GS Naidu, D Gur, M Aftalion, ... Nano Letters 21 (11), 4774-4779, 2021 | 23 | 2021 |
| Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice A Machlenkin, R Azriel-Rosenfeld, I Volovitz, E Vadai, A Lev, A Paz, ... Cancer Immunology, Immunotherapy 56, 217-226, 2007 | 22 | 2007 |
| Improved antibody-based ricin neutralization by affinity maturation is correlated with slower off-rate values R Rosenfeld, R Alcalay, A Mechaly, G Lapidoth, E Epstein, C Kronman, ... Protein Engineering, Design and Selection 30 (9), 611-617, 2017 | 18 | 2017 |
| Characterization of antibody-antigen interactions using biolayer interferometry T Noy-Porat, R Alcalay, A Mechaly, E Peretz, E Makdasi, R Rosenfeld, ... STAR protocols 2 (4), 100836, 2021 | 15 | 2021 |
| Directed evolution of therapeutic antibodies targeting glycosylation in cancer R Amon, R Rosenfeld, S Perlmutter, OC Grant, S Yehuda, ... Cancers 12 (10), 2824, 2020 | 14 | 2020 |
| The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants E Makdasi, A Zvi, R Alcalay, T Noy-Porat, E Peretz, A Mechaly, Y Levy, ... Cell Reports 36 (10), 2021 | 12 | 2021 |
